Vaccine developer Intravacc launches hybrid business model to drive innovation and growth |
September 16, 2021 | September 2021 Bond Updates |
BILTHOVEN, Netherlands, Sept. 16, 2021 /PRNewswire/ -- Intravacc, a global leader in translational research and the development of vaccines against infectious diseases and therapeutic vaccines, today launches its new hybrid business model that should lead to further innovation and... |
View more at: https://www.prnewswire.com:443/news-releases/vaccine-developer-intravacc-launches-hybrid-business-model-to-drive-innovation-and-growth-301378153.html |
Related News |